東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Treatment of inflammatory bowel dise...

Cheifetz, Adam S.

Linked to FindBook

Google Book

Amazon

博客來

Treatment of inflammatory bowel disease with biologics

Record Type:	Electronic resources : Monograph/item
Title/Author:	Treatment of inflammatory bowel disease with biologics/ edited by Adam S. Cheifetz, Joseph D. Feuerstein.
other author:	Cheifetz, Adam S.
Published:	Cham :Springer International Publishing : : 2018.,
Description:	xi, 335 p. :ill., digital ;24 cm.
[NT 15003449]:	Mechanism of Action and Pharmacokinetics of Biologics -- Anti-tumor Necrosis Factor Agents in Ulcerative Colitis -- Anti-tumor Necrosis Factor Agents in Crohn's Disease -- Anti-TNF Therapy for Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease -- Use of Biologics in the Postoperative Management of Crohn's Disease -- Biologics in Pregnancy and Breastfeeding -- Concomitant Use of Immunosuppressive Therapy with Tumor Necrosis Factor (TNF) Antagonists in Inflammatory Bowel Disease -- Therapeutic Drug Monitoring of Biologic Agents -- Use of Biologics in Crohn's Disease and Ulcerative Colitis Prior to Surgery and Perioperative Risks -- Cessation of Biologics - Can it be Done? -- Biologic Therapy in Pediatric Inflammatory Bowel Disease -- Infectious Complications of Biologics -- Tumor Necrosis Factor-Alpha Inhibitors and Risks of Malignancy -- Non-infectious and Non-malignant Complications of Biologics -- Biosimilars in Inflammatory Bowel Disease 2017: State of the Science, State of the Art, State of the Finances -- Anti-Integrin Agents in IBD: Efficacy and Risk of Complications -- Novel Agents in Inflammatory Bowel Disease -- Quality, Safety, and Practical Considerations of Using Biologic Therapies.
Contained By:	Springer eBooks
Subject:	Inflammatory bowel diseases - Chemotherapy. -
Online resource:	http://dx.doi.org/10.1007/978-3-319-60276-9
ISBN:	9783319602769

Treatment of inflammatory bowel disease with biologics
Treatment of inflammatory bowel disease with biologics[electronic resource] /edited by Adam S. Cheifetz, Joseph D. Feuerstein. - Cham :Springer International Publishing :2018. - xi, 335 p. :ill., digital ;24 cm.

Mechanism of Action and Pharmacokinetics of Biologics -- Anti-tumor Necrosis Factor Agents in Ulcerative Colitis -- Anti-tumor Necrosis Factor Agents in Crohn's Disease -- Anti-TNF Therapy for Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease -- Use of Biologics in the Postoperative Management of Crohn's Disease -- Biologics in Pregnancy and Breastfeeding -- Concomitant Use of Immunosuppressive Therapy with Tumor Necrosis Factor (TNF) Antagonists in Inflammatory Bowel Disease -- Therapeutic Drug Monitoring of Biologic Agents -- Use of Biologics in Crohn's Disease and Ulcerative Colitis Prior to Surgery and Perioperative Risks -- Cessation of Biologics - Can it be Done? -- Biologic Therapy in Pediatric Inflammatory Bowel Disease -- Infectious Complications of Biologics -- Tumor Necrosis Factor-Alpha Inhibitors and Risks of Malignancy -- Non-infectious and Non-malignant Complications of Biologics -- Biosimilars in Inflammatory Bowel Disease 2017: State of the Science, State of the Art, State of the Finances -- Anti-Integrin Agents in IBD: Efficacy and Risk of Complications -- Novel Agents in Inflammatory Bowel Disease -- Quality, Safety, and Practical Considerations of Using Biologic Therapies.

This book is a concise yet comprehensive overview of the use of biologics for the treatment of Crohn's disease and ulcerative colitis. The volume details how best to utilize these medications in order to optimize their efficacy and safety, as well as how to understand, recognize, and treat complications that may arise from using biologics to treat IBD. The text also focuses on new data, novel biologics, and biosimilars of this rapidly expanding field. Written by experts in the field, Treatment of Inflammatory Bowel Disease with Biologics is a valuable resource for gastroenterologists, allied health professionals, fellows, and trainees who treat patients with inflammatory bowel disease.

ISBN: 9783319602769

Standard No.: 10.1007/978-3-319-60276-9doiSubjects--Topical Terms:

3298952
Inflammatory bowel diseases
--Chemotherapy.

LC Class. No.: RC862.I53

Dewey Class. No.: 616.34406

Treatment of inflammatory bowel disease with biologics
LDR:02884nmm a2200313 a 4500 001 2132418
003 DE-He213
005 20180724142042.0
006 m d
007 cr nn 008maaau
008 181005s2018 gw s 0 eng d
020 $a 9783319602769 $q (electronic bk.)
020 $a 9783319602752 $q (paper)
024 7 $a 10.1007/978-3-319-60276-9 $2 doi
035 $a 978-3-319-60276-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RC862.I53
072 7 $a MJH $2 bicssc
072 7 $a MED031000 $2 bisacsh
082 0 4 $a 616.34406 $2 23
090 $a RC862.I53 $b T784 2018
245 0 0 $a Treatment of inflammatory bowel disease with biologics $h [electronic resource] / $c edited by Adam S. Cheifetz, Joseph D. Feuerstein.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a xi, 335 p. : $b ill., digital ; $c 24 cm.
505 0 $a Mechanism of Action and Pharmacokinetics of Biologics -- Anti-tumor Necrosis Factor Agents in Ulcerative Colitis -- Anti-tumor Necrosis Factor Agents in Crohn's Disease -- Anti-TNF Therapy for Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease -- Use of Biologics in the Postoperative Management of Crohn's Disease -- Biologics in Pregnancy and Breastfeeding -- Concomitant Use of Immunosuppressive Therapy with Tumor Necrosis Factor (TNF) Antagonists in Inflammatory Bowel Disease -- Therapeutic Drug Monitoring of Biologic Agents -- Use of Biologics in Crohn's Disease and Ulcerative Colitis Prior to Surgery and Perioperative Risks -- Cessation of Biologics - Can it be Done? -- Biologic Therapy in Pediatric Inflammatory Bowel Disease -- Infectious Complications of Biologics -- Tumor Necrosis Factor-Alpha Inhibitors and Risks of Malignancy -- Non-infectious and Non-malignant Complications of Biologics -- Biosimilars in Inflammatory Bowel Disease 2017: State of the Science, State of the Art, State of the Finances -- Anti-Integrin Agents in IBD: Efficacy and Risk of Complications -- Novel Agents in Inflammatory Bowel Disease -- Quality, Safety, and Practical Considerations of Using Biologic Therapies.
520 $a This book is a concise yet comprehensive overview of the use of biologics for the treatment of Crohn's disease and ulcerative colitis. The volume details how best to utilize these medications in order to optimize their efficacy and safety, as well as how to understand, recognize, and treat complications that may arise from using biologics to treat IBD. The text also focuses on new data, novel biologics, and biosimilars of this rapidly expanding field. Written by experts in the field, Treatment of Inflammatory Bowel Disease with Biologics is a valuable resource for gastroenterologists, allied health professionals, fellows, and trainees who treat patients with inflammatory bowel disease.
650 0 $a Inflammatory bowel diseases $x Chemotherapy. $3 3298952
650 0 $a Biologicals. $3 2045998
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Gastroenterology. $3 828956
700 1 $a Cheifetz, Adam S. $3 3298950
700 1 $a Feuerstein, Joseph D. $3 3298951
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-60276-9
950 $a Medicine (Springer-11650)